Viral Decision-Making Factors in Latent HIV Reservoirs Identified in Study – APhA submits compounding comments to FDA.

16321_pharmacyboard_standard_080416Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF

Viral Decision-Making Factors in Latent HIV Reservoirs Identified in Study – APhA submits compounding comments to FDA. – (866) 348-2889.

Research efforts have targeted latent HIV reservoirs as a potential way to guide future treatments. In a new study published in Cell Reports, the authors aimed to distinguish between uninfected cells and latently infected cells, with hopes that eradicating the latent reservoirs could lead to a cure for the disease.

In its latent state, the virus remains transcriptionally silent, but can spontaneously reactivate and trigger reinfection of the cell after treatment with antiretroviral therapy ends. Researchers have attempted to develop drug treatments that can both reactivate and remove cells with latent provirus. Challenges such as incomplete reactivation of non-inducible provirus, uncertainty regarding clearance or death of cells after latent reversal, and coupling of migration and reactivation of latently infected T cells have caused barriers to developing a successful strategy.

CLICK HERE FOR CONTINUE READING

This entry was posted in Pharmacist and tagged , , , . Bookmark the permalink.

Comments are closed.